These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 22806632)

  • 41. Sudden cardiac death in heart failure patients with preserved ejection fraction.
    Adabag S; Smith LG; Anand IS; Berger AK; Luepker RV
    J Card Fail; 2012 Oct; 18(10):749-54. PubMed ID: 23040109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
    Scherbakov N; Bauer M; Sandek A; Szabó T; Töpper A; Jankowska EA; Springer J; von Haehling S; Anker SD; Lainscak M; Engeli S; Düngen HD; Doehner W
    Eur J Heart Fail; 2015 Oct; 17(10):1015-21. PubMed ID: 26198713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipoprotein-associated phospholipase A2 activity in patients with preserved left ventricular ejection fraction.
    Moldoveanu E; Serban M; Marta DS; Serban I; Huica R
    Biomarkers; 2011 Nov; 16(7):587-9. PubMed ID: 21942556
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure.
    Watson CJ; Gupta SK; O'Connell E; Thum S; Glezeva N; Fendrich J; Gallagher J; Ledwidge M; Grote-Levi L; McDonald K; Thum T
    Eur J Heart Fail; 2015 Apr; 17(4):405-15. PubMed ID: 25739750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mitochondrial Morphology, Dynamics, and Function in Human Pressure Overload or Ischemic Heart Disease With Preserved or Reduced Ejection Fraction.
    Chaanine AH; Joyce LD; Stulak JM; Maltais S; Joyce DL; Dearani JA; Klaus K; Nair KS; Hajjar RJ; Redfield MM
    Circ Heart Fail; 2019 Feb; 12(2):e005131. PubMed ID: 30744415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gender differences in variables related to B-natriuretic peptide, left ventricular ejection fraction and mass, and peak oxygen consumption, in patients with heart failure.
    Tasevska-Dinevska G; Kennedy LM; Cline-Iwarson A; Cline C; Erhardt L; Willenheimer R
    Int J Cardiol; 2011 Jun; 149(3):364-71. PubMed ID: 20202706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension.
    van Heerebeek L; Hamdani N; Handoko ML; Falcao-Pires I; Musters RJ; Kupreishvili K; Ijsselmuiden AJ; Schalkwijk CG; Bronzwaer JG; Diamant M; Borbély A; van der Velden J; Stienen GJ; Laarman GJ; Niessen HW; Paulus WJ
    Circulation; 2008 Jan; 117(1):43-51. PubMed ID: 18071071
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency.
    Phan TT; Abozguia K; Nallur Shivu G; Mahadevan G; Ahmed I; Williams L; Dwivedi G; Patel K; Steendijk P; Ashrafian H; Henning A; Frenneaux M
    J Am Coll Cardiol; 2009 Jul; 54(5):402-9. PubMed ID: 19628114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction.
    Rusinaru D; Houpe D; Szymanski C; Lévy F; Maréchaux S; Tribouilloy C
    Eur J Heart Fail; 2014 Sep; 16(9):967-76. PubMed ID: 25111982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.
    MacDonell KL; Diamond J
    Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction.
    Hahn VS; Knutsdottir H; Luo X; Bedi K; Margulies KB; Haldar SM; Stolina M; Yin J; Khakoo AY; Vaishnav J; Bader JS; Kass DA; Sharma K
    Circulation; 2021 Jan; 143(2):120-134. PubMed ID: 33118835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea: a pressure-volume loop analysis.
    Penicka M; Bartunek J; Trakalova H; Hrabakova H; Maruskova M; Karasek J; Kocka V
    J Am Coll Cardiol; 2010 Apr; 55(16):1701-10. PubMed ID: 20394874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myocardial reverse remodeling: how far can we rewind?
    Rodrigues PG; Leite-Moreira AF; Falcão-Pires I
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1402-22. PubMed ID: 26993225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammatory pathways in patients with heart failure and preserved ejection fraction.
    Niethammer M; Sieber M; von Haehling S; Anker SD; Munzel T; Horstick G; Genth-Zotz S
    Int J Cardiol; 2008 Sep; 129(1):111-7. PubMed ID: 17658631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: results from the CIBIS-ELD trial.
    Loncar G; von Haehling S; Tahirovic E; Inkrot S; Mende M; Sekularac N; Lainscak M; Apostolovic S; Putnikovic B; Edelmann F; Wachter R; Dimkovic S; Waagstein F; Gelbrich G; Düngen HD
    Clin Biochem; 2012 Jan; 45(1-2):117-22. PubMed ID: 22155435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heart Failure With Preserved Ejection Fraction Induces Beiging in Adipose Tissue.
    Valero-Muñoz M; Li S; Wilson RM; Hulsmans M; Aprahamian T; Fuster JJ; Nahrendorf M; Scherer PE; Sam F
    Circ Heart Fail; 2016 Jan; 9(1):e002724. PubMed ID: 26721917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical characteristics and prognosis of heart failure with normal left ventricular ejection fraction in elderly patients.
    Liu DP; Wang F; Zeng XZ; Zhang XC
    Chin Med J (Engl); 2012 Aug; 125(16):2853-7. PubMed ID: 22932079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heart failure: what does ejection fraction have to do with it?
    Iwano H; Little WC
    J Cardiol; 2013 Jul; 62(1):1-3. PubMed ID: 23672790
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An herbal preparation ameliorates heart failure with preserved ejection fraction by alleviating microvascular endothelial inflammation and activating NO-cGMP-PKG pathway.
    Huang Y; Zhang K; Liu M; Su J; Qin X; Wang X; Zhang J; Li S; Fan G
    Phytomedicine; 2021 Oct; 91():153633. PubMed ID: 34320423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator.
    Kolijn D; Kovács Á; Herwig M; Lódi M; Sieme M; Alhaj A; Sandner P; Papp Z; Reusch PH; Haldenwang P; Falcão-Pires I; Linke WA; Jaquet K; Van Linthout S; Mügge A; Tschöpe C; Hamdani N
    Front Physiol; 2020; 11():345. PubMed ID: 32523538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.